News
LEO Pharma and Boehringer Ingelheim have entered into a partnership to commercialise and advance the development of ...
Just a few weeks after its approval in the UK, Bristol-Myers Squibb’s new oral psoriasis therapy Sotyktu has been recommended for routine NHS in England and Wales. The National Institute for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback